Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Effect of Medicare Dialysis Payment Reform on Use of Erythropoiesis Stimulating Agents
2014·25 Zitationen·Health Services ResearchOpen Access
Volltext beim Verlag öffnen25
Zitationen
4
Autoren
2014
Jahr
Abstract
CMS's payment reform for dialysis care reduced the use of ESAs in patients who may not benefit from these agents.
Ähnliche Arbeiten
The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay
1996 · 22.070 Zit.
Anemia of Chronic Disease
2005 · 3.703 Zit.
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
2006 · 2.733 Zit.
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 · 2.171 Zit.
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
2006 · 2.088 Zit.
Autoren
Institutionen
Themen
Erythropoietin and Anemia TreatmentDialysis and Renal Disease ManagementArtificial Intelligence in Healthcare and Education